glp-1 trial results today Mapping the effectiveness and risks of receptor agonists GLP-1 Users Who Track May

The other kind of neurons (GI) are those that decrease their frequency of potential actions when glucose rises

And if you still get backed up, Miralax works well

Last reviewed: July 8, 2026 Last updated: July 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

The specific how and why of the science may not be the focus for the majority, but the rapid impact of this evolving drug class is evident to see, from diabetes management and obesity treatment to the seemingly endless potential clinical promise

GLP-1 agonists have gained a tremendous amount of attention over the last few years for their potential to help people lose weight

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped